# Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion

> **NCT01042964** · PHASE1 · COMPLETED · sponsor: **AdvanceCor GmbH** · enrollment: 30 (actual)

## Conditions studied

- Thrombosis
- Acute Coronary Syndrome
- Myocardial Infarction
- Stroke

## Interventions

- **DRUG:** revacept (PR-15)

## Key facts

- **NCT ID:** NCT01042964
- **Lead sponsor:** AdvanceCor GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-01
- **Final completion:** 2007-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01042964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01042964, "Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01042964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*